RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, is pleased to announce the completion of the acquisition of the US-based Resco Group, from an ...

RHI Magnesita has over 20,000 employees in 67 main production sites, 12 recycling facilities and more than 70 sales offices RHI Magnesita trades on the the London Stock Exchange Resco operates seven ...

Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...

VIENNA - RHI Magnesita, the leading global supplier of refractory products, systems, and services, has announced the ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...

Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...

Construction is underway and will continue throughout 2025 on the rehabilitation of the decades-old Armco/AK Steel Research building in Middletown that when completed will be the combined home of ...

The global extrusion equipment market is set to witness a substantial compound annual growth rate (CAGR) of 5.3% throughout ...

The exhibitor registration deadline for Ceramitec 2026 is approaching. Cermitec will cover the entire spectrum of the ...